SCHEMBL8300729

SCHEMBL8300729

COc1ccc2c(c1)c(CC(=O)NN)c(C)n2Cc1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 19/20 1.00
MEN1 O00255 1/20 0.77
RGS12 O14924 1/20 0.77
ALDH1A1 P00352 1/20 0.77
LMNA P02545 1/20 0.77
CYP1A2 P05177 1/20 0.77
CYP3A4 P08684 1/20 0.77
MAPT P10636 1/20 0.77
CYP2C9 P11712 1/20 0.77
PKM P14618 1/20 0.77
TSHR P16473 1/20 0.77
NFKB1 P19838 1/20 0.77
MAPK1 P28482 1/20 0.77
CYP2C19 P33261 1/20 0.77
GNAI1 P63096 1/20 0.77
PMP22 Q01453 1/20 0.77
KMT2A Q03164 1/20 0.77
HIF1A Q16665 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8296281 0.95 PLA2G2A (0.90) PLA2G2AMEN1RGS12ALDH1A1LMNA
SCHEMBL8291800 0.92 PLA2G2A (0.85) PLA2G2A
SCHEMBL7961561 0.91 PLA2G2A (1.00) PLA2G2A
SCHEMBL7953268 0.90 PLA2G2A (1.00) PLA2G2A
SCHEMBL8296701 0.89 PLA2G2A (0.81) PLA2G2A
SCHEMBL8296706 0.88 PLA2G2A (1.00) PLA2G2AMEN1RGS12ALDH1A1LMNA
SCHEMBL8298662 0.88 PLA2G2A (1.00) PLA2G2A
SCHEMBL1322507 0.87 LMNA (1.00) PLA2G2AMEN1RGS12ALDH1A1LMNA
SCHEMBL7964308 0.87 PLA2G2A (1.00) PLA2G2A
SCHEMBL8297412 0.86 PLA2G2A (0.87) PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0620214-B1 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors LILLY CO ELI (US) 1999-03-03 EP disclosed
US-5578634-A SEPTIC SHOCK TREATMENT ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0620214-A1 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1994-10-19 EP disclosed